Showing results (1331-1340 of 1,700) with videos related to

Sort By:
Pageof 170
JACC. Cardiovascular Interventions|November 27, 2024
Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding RiskMarco Roffi, Antonio Landi, Dik Heg, et al.
JACC. Cardiovascular Interventions|April 24, 2024
Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk PatientsNeal S Kleiman, Nicolas M Van Mieghem, Michael J Reardon, et al.
JACC. Cardiovascular Interventions|December 20, 2014
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Patrick W Serruys, Takashi Muramatsu, et al.
JACC. Cardiovascular Interventions|August 7, 2017
Transcatheter Tricuspid Valve Repair With a New Transcatheter Coaptation System for the Treatment of Severe Tricuspid Regurgitation: 1-Year Clinical and Echocardiographic ResultsGidon Perlman, Fabien Praz, Rishi Puri, et al.
Circulation. Cardiovascular Interventions|September 13, 2017
Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Maik J Grundeken, Shimpei Nakatani, et al.
JACC. Cardiovascular Interventions|January 25, 2023
Transient vs In-Hospital Persistent Acute Kidney Injury in Patients With Acute Coronary SyndromeAntonio Landi, Mattia Branca, Sergio Leonardi, et al.
American Heart Journal|February 10, 2016
Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trialHolger Thiele, Steffen Desch, Jan J Piek, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 21, 2023
Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trialSarah Bär, Raminta Kavaliauskaite, Tatsuhiko Otsuka, et al.
Nature Reviews. Cardiology|January 19, 2020
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular diseaseDavide Capodanno, Deepak L Bhatt, John W Eikelboom, et al.
European Heart Journal|May 20, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on ThrombosisValeria Paradies, Giulia Masiero, Andrea Rubboli, et al.
Pageof 170